The Efficacy and Safety of Cilostazol vs. Aspirin for Secondary Stroke Prevention: A Systematic Review and Meta-Analysis.

Chai, Erqing; Chen, Jinhua; Li, Changqing; Zhang, Xue; Fan, Zhiqiang; Yang, Shijie; Zhao, Kaixuan; Li, Wei; Xiao, Zaixing; Zhang, Yichuan; Tang, Futian

Chai, Erqing; Chen, Jinhua; Li, Changqing; Zhang, Xue; Fan, Zhiqiang; Yang, Shijie; Zhao, Kaixuan; Li, Wei; Xiao, Zaixing; Zhang, Yichuan; Tang, Futian.

Afiliação

Chai E; Cerebrovascular Disease Center, Gansu Provincial Hospital, Lanzhou, China.
Chen J; Emergency General Hospital, Beijing, China.
Li C; The First School of Clinical Medicine, Lanzhou University, Lanzhou, China.
Zhang X; Cerebrovascular Disease Center, Gansu Provincial Hospital, Lanzhou, China.
Fan Z; Intensive Care Unit 1, Gansu Provincial Hospital, Lanzhou, China.
Yang S; First Clinical Medical College, Gansu University of Chinese Medicine, Lanzhou, China.
Zhao K; First Clinical Medical College, Gansu University of Chinese Medicine, Lanzhou, China.
Li W; School of Clinical Medicine, Ningxia Medical University, Ningxia, China.
Xiao Z; First Clinical Medical College, Gansu University of Chinese Medicine, Lanzhou, China.
Zhang Y; First Clinical Medical College, Gansu University of Chinese Medicine, Lanzhou, China.
Tang F; School of Clinical Medicine, Ningxia Medical University, Ningxia, China.

Front Neurol ; 13: 814654, 2022.

Article em En | MEDLINE | ID: mdl-35242099

Palavras-chave

aspirin; cilostazol; efficacy and safety; stroke prevention; systematic review and meta-analysis

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies / Systematic_reviews Idioma: En Revista: Front Neurol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google